Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma.

Win KT, Lee MY, Tan TD, Tsai MP, Bahrami A, Raimondi SC, Chuang SS.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):451-5. eCollection 2014.

2.

Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.

Yasuda T, Perry KD, Nelson M, Bui MM, Nasir A, Goldschmidt R, Gnepp DR, Bridge JA.

Hum Pathol. 2009 Mar;40(3):341-8. doi: 10.1016/j.humpath.2008.08.006. Epub 2008 Oct 29.

3.

Alveolar rhabdomyosarcoma mimicking nasal lymphoma at the initial presentation.

Ihara T, Okamura D, Takahashi N, Kohri M, Kayano H, Tamaru J, Niitsu N.

J Clin Exp Hematop. 2008 Nov;48(2):61-4.

4.

Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.

Kazanowska B, Reich A, Stegmaier S, Békássy AN, Leuschner I, Chybicka A, Koscielniak E.

Fetal Pediatr Pathol. 2007 Jan-Feb;26(1):17-31.

PMID:
17613043
5.

Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14).

Frascella E, Lenzini E, Schafer BW, Brecevic L, Dorigo E, Toffolatti L, Nanni P, De Giovanni C, Rosolen A.

Cancer Genet Cytogenet. 2000 Sep;121(2):139-45.

PMID:
11063797
6.

Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.

Takata K, Hong ME, Sitthinamsuwan P, Loong F, Tan SY, Liau JY, Hsieh PP, Ng SB, Yang SF, Pongpruttipan T, Sukpanichnant S, Kwong YL, Hyeh Ko Y, Cho YT, Chng WJ, Matsushita T, Yoshino T, Chuang SS.

Am J Surg Pathol. 2015 Jan;39(1):1-12. doi: 10.1097/PAS.0000000000000312.

PMID:
25188863
7.

Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.

Mehra S, de la Roza G, Tull J, Shrimpton A, Valente A, Zhang S.

Diagn Mol Pathol. 2008 Mar;17(1):14-20. doi: 10.1097/PDM.0b013e3181255e62.

PMID:
18303411
8.

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.

Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG.

J Clin Oncol. 2002 Jun 1;20(11):2672-9.

PMID:
12039929
9.

Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.

Cerveira N, Torres L, Ribeiro FR, Henrique R, Pinto A, Bizarro S, Ferreira AM, Lopes C, Teixeira MR.

Cancer Genet Cytogenet. 2005 Dec;163(2):138-43.

PMID:
16337856
10.

The utility of FOXO1 fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded specimens in the diagnosis of alveolar rhabdomyosarcoma.

Downs-Kelly E, Shehata BM, López-Terrada D, Weaver J, Patel RM, Hartke M, Tubbs RR, Skacel M, Goldblum JR.

Diagn Mol Pathol. 2009 Sep;18(3):138-43. doi: 10.1097/PDM.0b013e31818c2ea4.

PMID:
19704258
11.

Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?

Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J, Pritchard-Jones K; UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group.

Br J Cancer. 2001 Sep 14;85(6):831-5.

12.

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.

Blood. 1997 Jun 15;89(12):4501-13. Review.

13.

Detection of alveolar rhabdomyosarcoma in pleural fluid with immunocytochemistry on cell block and determination of PAX/FKHR fusion mRNA by reverse transcription-polymerase chain reaction.

Sawangpanich R, Larbcharoensub N, Jinawath A, Pongtippan A, Anurathapan U, Hongeng S.

J Med Assoc Thai. 2011 Nov;94(11):1394-8.

PMID:
22256481
14.

Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma.

Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA.

Lab Invest. 2006 Jun;86(6):547-56.

15.

PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.

Chang B, Pang LJ, Qi Y, Liu CX, Cao Y, Li HA, Hu WH, Jiang JF, Zhang WJ, Li F.

Int J Surg Pathol. 2009 Feb;17(1):6-15. doi: 10.1177/1066896908323922. Epub 2008 Nov 6.

PMID:
18988640
16.
18.

Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.

Ding W, Wang J, Zhao S, Yang Q, Sun H, Yan J, Gao L, Yao W, Zhang W, Liu W.

Pathol Res Pract. 2015 Jul;211(7):544-9. doi: 10.1016/j.prp.2015.04.002. Epub 2015 Apr 17. Review.

PMID:
25953340
19.

Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells.

Massuda ES, Dunphy EJ, Redman RA, Schreiber JJ, Nauta LE, Barr FG, Maxwell IH, Cripe TP.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14701-6.

20.

Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.

Heerema-McKenney A, Wijnaendts LC, Pulliam JF, Lopez-Terrada D, McKenney JK, Zhu S, Montgomery K, Mitchell J, Marinelli RJ, Hart AA, van de Rijn M, Linn SC.

Am J Surg Pathol. 2008 Oct;32(10):1513-22. doi: 10.1097/PAS.0b013e31817a909a.

PMID:
18708938

Supplemental Content

Support Center